Table 1.
Clinical characteristics comparisons between non-CAHD and CAHD patients
| Non-CAHD group | CAHD group | t/χ2 | P | |
|---|---|---|---|---|
| N = 678 | N = 2771 | |||
| Age (y) | 63.14 ± 11.51 | 63.92 ± 11.27 | 1.609 | 0.120 |
| Male (No.) | 451 (66.52%) | 1960 (70.73%) | 4.597 | 0.032 |
| Smoking (No.) | 231 (34.07%) | 923 (33.31%) | 0.142 | 0.706 |
| Overweighta (No.) | 187 (27.58%) | 743 (26.81%) | 0.163 | 0.686 |
| Diabetes (No.) | 367 (54.13%) | 1720 (62.07%) | 14.377 | < 0.001 |
| Hypertension (No.) | 382 (56.34%) | 1610 (58.10%) | 0.691 | 0.406 |
| Family historyb (No.) | 112 (16.52%) | 419 (15.12%) | 0.818 | 0.366 |
| TC (mg/dL) | 176.27 ± 40.85 | 175.56 ± 36.31 | 0.414 | 0.679 |
| TG (mg/dL) | 157.03 ± 81.19 | 172.20 ± 98.23 | 4.175 | < 0.001 |
| HDL-C (mg/dL) | 47.79 ± 8.80 | 45.08 ± 8.04 | 7.307 | < 0.001 |
| LDL-C (mg/dL) | 88.08 ± 33.35 | 83.94 ± 28.21 | 2.982 | 0.003 |
| non-HDL-C (mg/dL) | 128.48 ± 38.91 | 130.48 ± 35.46 | 1.220 | 0.223 |
| Lp(a)c (nmol/L) | 56.69 ± 62.37 | 67.88 ± 72.22 | 4.054 | < 0.001 |
| Apo-A1 (mg/dL) | 134.04 ± 16.03 | 128.13 ± 14.97 | 8.715 | < 0.001 |
| Apo-B (mg/dL) | 82.44 ± 24.55 | 84.45 ± 20.81 | 1.966 | 0.050 |
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); apo(a)1, apolipoprotein(a)1; apoB, apolipoprotein B
aOverweight was defined as body mass index (BMI) > 28 (BMI = weight (kg)/height (m))
bFamily history was defined as one or more parents or grandparents diagnosed with CAHD
cLp(a) was skewed, and differences between groups are judged by Mann–Whitney U